Business Wire

Aviceda Announces FDA Clearance of the Investigational New Drug (IND) Application for AVD-104, a Novel Glyco-Mimetic Nanoparticle, Enabling Initiation of Phase 2 Clinical ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aviceda Therapeutics, a private clinical-stage biotech company focused on developing next generation immuno-modulators by harnessing the power of glycobiology to ...
ZDNet

Microsoft rebrands WVD as 'Azure Virtual Desktop'; adds new app-streaming pricing option

Microsoft is rebranding its Windows Virtual Desktop (WVD) service as "Azure Virtual Desktop." At the same time, the company is introducing a new ISV/per-user pricing option and taking the wraps off a ...
Business Wire

Aviceda Announces Successful Submission of an Investigational New Drug (IND) and Fast Track Designation (FTD) Application for AVD-104 for the Treatment of Geographic Atrophy ...

Aviceda Therapeutics has completed a key regulatory milestone for its HALOS™ (High-Affinity Ligands of Sigelcs) technology platform and its lead ophthalmic drug candidate, AVD-104, a novel ...